Allarity Therapeutics, Inc. Gain (Loss) on Extinguishment of Debt
Allarity Therapeutics, Inc. (ALLR) had Gain (Loss) on Extinguishment of Debt of $69.00 thousand as of 2024-03-14, per its 10-Q filed 2024-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-08-05
- Allarity Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $333.00K.
- Allarity Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was -$333.00K.
- Allarity Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-06-30 was -$25.00K.
- Allarity Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-03-31 was -$116.00K.
- Allarity Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was -$141.00K.
- Allarity Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was -$108.00K.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt as first filed | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|---|
| 2024-03-14 | $69.00K 10-Q · filed 2024-08-05 | $69.00 10-Q · filed 2024-05-14 | ||||
| 2024-02-14 | $122.00K 10-Q · filed 2024-08-05 | |||||
| 2021-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | -$25.00K derived: sum of 3 quarters · filed 2023-03-13 | -$141.00K 10-K · filed 2023-03-13 | ||
| 2021-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$358.00K derived: sum of 2 quarters · filed 2022-11-14 | -$474.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$25.00K 10-Q · filed 2022-10-07 | -$141.00K 10-Q · filed 2022-10-07 | ||||
| 2021-03-31 | -$116.00K 10-Q · filed 2022-05-27 | |||||
| 2020-12-31 | -$108.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |